-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.O2.6 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Deciphering Risk by Genetic and Epigenetic Features

Symposia: Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Translational Research, Clinical Research, Diseases, Myeloid Malignancies
Monday, December 11, 2023: 2:45 PM-4:15 PM
Pacific Ballroom Salons 15-17 (Marriott Marquis San Diego Marina)
Moderators:
Philipp A. Greif, MD, Ludwig-Maximilians-Universität and Helmholtz Zentrum München and Sarah K Tasian, MD,
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Francisco Marchi1, Marieke Landwehr1*, Fernando Sckaff2*, Xueyuan Cao, PhD3,4*, Raul C. Ribeiro, MD5, Jeffrey E. Rubnitz, MD, PhD5,6, Alan S Gamis, MD, MPH7, E. Anders Kolb, MD8, Richard Aplenc, MD, PhD9,10, Stanley Pounds, PhD11*, Todd A. Alonzo, PhD12,13*, Soheil Meshinchi, MD, PhD14 and Jatinder K. Lamba, PhD15,16

1Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL
2University of Florida, Gainesville
3Department of Health Promotion and Disease Prevention, University of Tennessee Health Science Center, Memphis, TN
4St. Jude Children's Research Hospital, Memphis, TN
5Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
6St. Jude Children's Hospital, Memphis, TN
7Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO
8Leukemia & Lymphoma Society, Bronx, NY
9Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
10Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
11Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
12Univ. of Southern California Keck School of Med., Monrovia, CA
13Children's Oncology Group, Monrovia, CA
14Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA
15Umn Center For Allied Health Programs, Gainesville, FL
16UF Health Cancer Center, University of Florida, Gainesville, FL

3:00 PM

Yotaro Ochi, MD, PhD1*, Yasuhito Nannya, MD, PhD1,2, Markus Liew-Littorin3*, Senji Kasahara, MD, PhD4*, Nobuhiro Hiramoto, MD5*, Nobuhiro Kanemura, MD, PhD6, Nobuo Sezaki7*, Maki Sakurada8*, Makoto Iwasaki, MD, PhD9*, Junya Kanda, MD, PhD10*, Yasunori Ueda, MD, PhD11, Satoshi Yoshihara, MD, PhD12, Albin Osterroos, MD13*, Masanori Motomura1*, Masahiro Marshall Nakagawa, MD, PhD1, Ryunosuke Saiki1*, Akinori Yoda, PhD1*, Rurika Okuda, MSc, BS1*, Yuichi Shiraishi14*, Takayuki Ishikawa, MD15, Satoru Miyano14,16*, Akifumi Takaori-Kondo, MD, PhD8, Soren Lehmann, MD, PhD13,17* and Seishi Ogawa18,19,20

1Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
2Division of Hematopoietic Disease Control, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
3Division of Hematology, Department of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
4Department of Hematology, Gifu Municipal Hospital, Gifu, Japan
5Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
6Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan
7Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan
8Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
9Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Nara, NAR, Japan
10Department of Hematology / Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan
11Department of Hematology/Oncology, Transfusion and Hemapheresis Center, Kurashiki Central Hospital, Kurashiki, Japan
12Department of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan
13Department of Medical Sciences, Hematology, Uppsala University, Uppsala, Sweden
14Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
15Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
16Department of Integrated Analytics, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
17Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
18Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden
19Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan
20Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine, Sakyoku, KYO, Japan

3:15 PM

Andrew Stiff, MD, PhD1, Deedra Nicolet2, Maarten Fornerod, PhD3*, Ben Kelly4*, Katherine Miller5*, Krzysztof Mrózek, MD, PhD6, Isaiah Boateng7*, Bailee Nicole Kain, PhD8*, Elizabeth Garfinkle, BS9*, Eileen Y Hu, BS10*, Saranga Wijeratne5,9*, Gregory Wheeler9*, Christopher J. Walker, PhD2*, Jill Buss, BS6, Adrienne Heyrosa7*, Helee Desai7*, Andrea Laganson, MS11*, Yazan Abu-Shihab, MD12*, Hasan Abaza7*, Alice Mims, MD13, Christopher C. Oakes, PhD14, Bethany L Mundy-Bosse, PhD15, Andrew J Carroll, PhD16, Bayard L Powell, MD17, Jonathan E Kolitz, MD18, Richard Stone19, Electra D Paskett, PhD20*, Ross L Levine, MD21, Kamal Menghrajani, MD22, Debyani Chakravarty, PhD23*, Michael F. Berger, PhD23*, Nathan Salomonis, PhD24*, Daniel Bottomly25*, Shannon K McWeeney, PhD25*, Jeffrey W Tyner, PhD26, John C. Byrd, MD27, H. Leighton Grimes, PhD8, Elaine R Mardis, PhD7,28,29* and Ann-Kathrin Eisfeld, MD*2,29

1Depatment of Internal Medicine, Division of Hematology, Ohio State University, Columbus, OH
2Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
3Erasmusmc Sophia, Rotterdam, ZH, NLD
4Nationwide Children's Hospital and Ohio State University College of Medine, Columbus, OH
5The Steve and Cindy Rasmussen Institute For Genomic Medicine, Abigail Wexner Res, Columbus, OH
6Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
7The Ohio State University Comprehensive Cancer Center, Columbus, OH
8Cincinnati Children's Hospital Medical Center, Cincinnati, OH
9The Steve and Cindy Rasmussen Institute For Genomic Medicine, Nationwide Children's Hospital, Columbus, OH
10University of Texas Southwestern, Dallas, TX
11Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus
12The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
13Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
14Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
15Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
16Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
17Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
18Northwell Cancer Center, Hofstra/Northwell School of Medicine, Lake Success, NY
19Dana-Farber Cancer Institute, Boston, MA
20Department of Internal Medicine, Division of Cancer Prevention and Control, The Ohio State University Comprehensive Cancer Center, Columbus, OH
21Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
22MSKCC Memorial Sloan Kettering Cancer Center, New York, NY
23Memorial Sloan-Kettering Cancer Center, New York, NY
24Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
25Knight Cancer Institute, Oregon Health & Science University, Portland, OR
26Knight Cancer Institute, Oregon Health and Science University, Portland, OR
27Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
28Nationwide Children's Hospital, Columbus, OH
29Contributed equally, #

3:30 PM

Juan Barajas, PhD1, Masayuki Umeda, MD, PhD2, Jing Ma, PhD2*, Mahsa Khanlari, MD1, Michael P Walsh, PhD1*, Tamara Westover, BS2, Lisett Contreras, PhD1*, Guangchun Song2*, Xiaotu Ma, PhD1, Melvin Thomas III, PhD1 and Jeffery M. Klco, MD, PhD1

1St. Jude Children's Research Hospital, Memphis, TN
2Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN

3:45 PM

Diego Pereira-Martins, PhD1*, César Alexander Ortiz Rojas, Ph.D.2*, Isabel Weinhaeuser, PhD1*, Bart-Jan Wierenga, PhD1*, Vincent Van Den Boom, Ph.D.1*, Fatemeh Mojallali, MSc1*, Dominique Sternadt, MSc1*, Thiago Mantello Bianco, Ph.D.3*, Nisha van der Meer, MD, MSc1*, Douglas RA Silveira, MD, PhD4*, Lynn Quek, MD, PhD5*, Emanuele Ammatuna, MD, PhD1*, Antonio R Lucena-Araujo, Prof.6*, Gerwin A. Huls, Prof.7, Eduardo Magalhães Rego, MD, PhD8,9 and Jan Jacob Schuringa, PhD10

1Department of Experimental Hematology, University Medical Centre Groningen, Groningen, Netherlands
2Department of Internal Medicine, Medical School of Ribeirao Preto and the Center for Cell Based Therapy, University of São Paulo, Sao Paulo, Brazil
3Department of Medical Images, Haematology, and Clinical Oncology, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil
4School of Cancer and Pharmaceutical Sciences, King's College London, London, ENG, United Kingdom
5Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom
6Department of Genetics, Federal University of Pernambuco, Recife, Brazil
7Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
8Hematology Service, LIM-31 and State of Sao Paulo Cancer Institute, University of São Paulo, Faculdade de Medicina, São Paulo, São Paulo, Brazil
9Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, BRA
10Department of Experimental Hematology, University Medical Center - Groningen, Groningen, Netherlands

4:00 PM

Martina Pigazzi, PhD1,2*, Claudia Tregnago, PhD1*, Rhonda E Ries, MA3*, Maddalena Benetton, PhD1*, Todd A. Alonzo, PhD4*, Nicolas Duployez, PharmD, PhD5*, Edwin Sonneveld, PhD6*, Jonas Abrahamsson7*, Linda Fogelstrand, MD, PhD8, Nils Von Neuhoff, PhD9*, Henrik Hasle10, Dirk Reinhardt, MD11, Franco Locatelli, MD, PhD12 and Soheil Meshinchi, MD, PhD13

1Department of Women's and Children's Health, Onco-hematology lab and clinic, University of Padova, Padova, Italy
2Foundation Istituto Ricerca Pediatrica (IRP), Padova, Italy
3Translational Sciences and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
4Children's Oncology Group, Monrovia, CA
5Hôpital Claude Huriez, Lille, France
6Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
7Institute of Clinical Sciences, Department of Pediatrics, Queen Silvias Childrens Hospital, Gothenburg, Sweden
8Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
9Department of Pediatric Hematology and Oncology, University Hospital Essen, Germany, Essen, Germany
10Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
11Department of Pediatrics III, University Children’s Hospital Essen, University of Duisburg-Essen, Essen, Germany
12Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Bambino Gesù Children's Hospital, Catholic University of the Sacred Heart, Roma, Italy
13Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA

*signifies non-member of ASH